AMPLITUDE: a Phase 3 Clinical Trial of Niraparib Combined with Abiraterone Acetate for HRR-Deficient Metastatic Castration-Sensitive Prostate Cancer

/in , , /by
Read more

Scientists Develop “Velcro” Cancer Treatment That Works Across Many Tumor Types

/in , /by

Researchers at the University of California, Irvine have developed an innovative cancer immunotherapy called GlyTR, a new class of treatment that uses a “velcro-like” mechanism to target sugar molecules abundantly present on cancer cells. Their findings were published in September 2025 in the prestigious journal Cell, marking a significant advancement in cancer immunotherapy. Traditional immunotherapies […]

Read more

New Study Uncovers Mechanism Behind T-Cell Exhaustion, Offering Hope for Prostate Cancer Immunotherapy

/in , /by

A study from The Ohio State University Comprehensive Cancer Center has illuminated a critical reason why cancer immunotherapy often fails: T-cell exhaustion driven by a novel stress pathway called TexPSR (proteotoxic stress response in T-cell exhaustion). Published in the prestigious journal Nature, this discovery reveals a proteotoxic shock in exhausted T cells caused by the […]

Read more

LUNAR Trial Shows Combination Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer

/in , , /by
Read more

Newsletter 40/2025

/in /by

LAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! ​A quick note from me: our newsletter runs on Kit.com, which costs $290/year to keep going. If you enjoy these updates and would like to chip in to help cover the renewal, you can do so here, or send me a […]

Read more